SERC Tablets 16 Milligram

국가: 아일랜드

언어: 영어

출처: HPRA (Health Products Regulatory Authority)

지금 구매하세요

제품 특성 요약 제품 특성 요약 (SPC)
28-04-2024

유효 성분:

BETAHISTINE HYDROCHLORIDE

제공처:

B & S Healthcare

복용량:

16 Milligram

약제 형태:

Tablets

승인 날짜:

2006-08-11

제품 특성 요약

                                IRISH MEDICINES BOARD ACT 1995
MEDICINAL PRODUCTS(LICENSING AND SALE)REGULATIONS, 1998
(S.I. NO.142 OF 1998)
PPA1328/034/001
Case No: 2034068
The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants
to
B & S HEALTHCARE
UNIT 4, BRADFIELD ROAD, RUISLIP, MIDDLESEX, HA4 0NU, UNITED KINGDOM
an authorisation, subject to the provisions of the said Regulations, in respect of the product
SERC 16 MG TABLETS
The particulars of which are set out in Part I and Part II of the attached Schedule. The authorisation is also subject to
the general conditions as may be specified in the said Regulations as listed on the reverse of this document.
This authorisation, unless previously revoked, shall continue in force from 26/03/2007 until 10/08/2011.
Signed on behalf of the Irish Medicines Board this
________________
A person authorised in that behalf by the said Board.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 12/04/2007_
_CRN 2034068_
_page number: 1_
PART II
SUMMARY OF PRODUCT CHARACTERISTICS
4 CLINICAL PARTICULARS
5 PHARMACOLOGICAL PROPERTIES
6 PHARMACEUTICAL PARTICULARS
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 12/04/2007_
_CRN 2034068_
_page number: 2_
                                
                                전체 문서 읽기
                                
                            

이 제품과 관련된 검색 알림